Literaturverzeichnis

Transkript

1 Literaturverzeichnis Prof. Dr. med. Matthias D. Becker, MSc Stand: 21. Juli 2013 Wissenschaftliche Zeitschriften 1. Becker M, Menger MD, Lehr HA: Heparin-released superoxide dismutase inhibits postischemic leukocyte adhesion to venular endothelium. Am. J. Physiol. 1994, 267:H925-H Becker MD, Kruse FE, Joussen AM, Rohrschneider K, Nobiling R, Gebhard MM, Völcker HE: In vivo fluorescence microscopy of corneal neovascularization. Graefes Arch Clin Exp Ophthalmol 1998, 236: Becker MD, Kruse FE, Azzam L, Nobiling R, Gebhard MM, Reichling J, Völcker HE: In vivo significance of ICAM-1 dependent leukocyte adhesion in early corneal angiogenesis. Invest Ophthalmol Vis Sci 1999, 40: Becker MD, Nobiling R, Planck SR, Rosenbaum JT: Digital videoimaging of leukocyte migration in the iris: intravital microscopy in a physiological model during the onset of endotoxin- induced uveitis. J Immunol Methods 2000, 240: Becker MD, O'Rourke LM, Blackman WS, Planck SR, Rosenbaum JT: Reduced leukocyte migration, but normal rolling and arrest, in interleukin-8 receptor homologue knockout mice. Invest Ophthalmol Vis Sci 2000, 41: Becker MD, Adamus G, Davey MP, Rosenbaum JT: The role of T-cells in autoimmune uveitis. Ocul Immunol Inflamm 2000, 8: (invited review) 7. Becker MD, Crespo S, Martin TM, Planck SR, Naramura M, Rosenbaum JT: Intraocular in vivo imaging of activated T- lymphocytes expressing green- fluorescent protein after stimulation with endotoxin. Graefes Arch Clin Exp Ophthalmol 2001, 239: Becker MD, Whitcup S, Crespo S, Garman K, Planck SR, Rosenbaum JT: Inhibition of leukocyte sticking and infiltration, but not rolling, by antibodies to ICAM-1 and LFA-1 in murine endotoxin-induced

2 uveitis. Invest Ophthalmol Vis Sci 2001, 42: Becker MD, Dullforce PA, Martin TM, Smith JR, Planck SR, Rosenbaum JT: Immune mechanisms in uveitis: What can be learned from in vivo imaging? Ophthalmol Clin North Am 2002, 15: (invited review) 10. Becker MD, Planck SR, Crespo S, Garman K, Fleischman RJ, Dullforce P, Seitz GW, Martin TM, Parker DC, Rosenbaum JT: Immunohistology of antigen-presenting cells in vivo: a novel method for serial observation of fluorescently labelled cells. Invest Ophthalmol Vis Sci 2003, 44: Neumann E, Frei E, Funk D, Becker MD, Schrenk HH, Müller-Ladner U, Fiehn C: Native albumin for targeted drug delivery. Expert Opin Drug Deliv : Klinische Zeitschriften 12. Becker M, Rohrschneider K: Ocular manifestations of Wilson disease. Ophthalmologe 1997, 94: Becker M, Rohrschneider K, Tilgen W, Weber BHF, Völcker HE: Familiar juvenil macular dystrophy with congenital hypotrichosis capitis. Ophthalmologe 1998, 95: Becker MD, Rosenbaum JT: Essential laboratory tests in uveitis. Dev Ophthalmol 1999, 31: (invited review) 15. Becker MD, Rosenbaum JT: Current and future trends in the use of immunosuppressive agents in patients with uveitis. Curr Opin Ophthalmol 2000, 11: (invited review) 16. Becker MD: Vitrektomie bei Uveitis mehr Durchblick? Ophthalmologe 2003, 100: (invited review) 17. Becker MD, Harsch N, Zierhut M, Davies JL, Holz FG: Therapeutische Vitrektomie bei Uveitis. Ophthalmologe 2003, 100: (invited review) 18. Becker MD, Bodaghi B, Holz FG, Harsch N, Le Hoang P: Diagnostische Vitrektomie bei Uveitis. Ophthalmologe 2003, 100: (invited review) 19. Becker MD, Smith JR, Max R, Fiehn C: Management of Sight- Threatening Uveitis: New Therapeutic Options. Drugs 2005, 65: (invited review)

3 20. Becker MD: Therapeutische Vitrektomie bei Uveitis Aktueller Stand und Empfehlungen. Z prakt Augenheilkd 2004, 25: (invited review) 21. Becker MD Strategien zur immunsuppressiven Therapie intraokularer Entzündungen. Ophthalmologe 2005, 102: Becker MD, Heiligenhaus A, Hudde T, Storch-Hagenlocher B, Wildemann B, Barisani-Asenbauer T, Thimm C, Stübiger N, Trieschmann M, Fiehn C: Interferon as a Treatment for Uveitis Associated with Multiple Sclerosis. Br J Ophthalmol 2005, 89: Becker MD, Zierhut M: Das Fuchs sche Uveitis Syndrom die Heterochromie ist keine conditio sine qua non. Ophthalmologe 2005,102: ; Quiz Becker MD, Wertheim MS, Smith JR, Rosenbaum JT: Long-term Follow-up of patients with Birdshot retinochoroidopathy treated with systemic immunosuppression. Ocular Immunol Inflamm 2005, 13: Becker MD: Strategien zur Diagnostik intraokularer Entzündungen. Augenspiegel 2005, 4: Becker MD, Heiligenhaus A: Strategien der immunsuppressiven Therapie für den Augenarzt. Z prakt Augenheilkd 2005, 26: Becker MD: Operative Möglichkeiten bei intraokularen Entzündungen. Augenspiegel 2005, 9: Becker MD, Davis JL: Vitrectomy in the Treatment of Uveitis. Am J Ophthalmol 2005, 140: (Perspective Article) 29. Becker MD, Mackensen F: Endophthalmitis Aktuelle Empfehlungen, neue Leitlinien. Augenspiegel 2006, 9: Becker MD, Max R: Uveitis bei Älteren: Systemassoziationen und Therapie mit Immunsuppressiva. Z prakt Augenheilkd 2006, 27: Becker MD: Uveitis ist behandelbar. Pharm Ztg 2007, 32: Becker MD: Endophthalmitis. Ophthalmologe 2007;104: Becker MD, Mackensen F: Therapie der akuten postoperativen Endophthalmitis Behandlung eines medizinischen Notfalls. Ophthalmologe 2007, 104:

4 Koautorschaften bei Orginalpublikationen 34. Nolte D, Bayer M, Lehr HA, Becker M, Krombach A, Kreimeier U, Messmer K: Attenuation of postischemic microvascular disturbances in striated muscle by hyperosmolar saline dextrane. Am J Physiol 1992, 263: H1411-H Lehr HA, Becker M, Marklund SL, Hübner C, Arfors KE, Kohlschütter A, Messmer K: Superoxide-dependent stimulation of leukocyte adhesion by oxidatively modified LDL in vivo. Atherosclerosis and Thrombosis 1992, 12: Rohrschneider K, Becker M, Fendrich T, Volcker HE: Kinetic fundus controlled perimetry with the scanning laser ophthalmoscope. Klin Monatsbl Augenheilkd 1995, 207: Rohrschneider K, Becker M, Kruse FE, Fendrich T, Völcker HE: Stability of fixation - results of fundus-controlled examination using the Scanning Laser Ophthalmoscope. German J Ophthalmol 1995, 4: Rohrschneider K, Fendrich T, Becker M, Krastel H, Kruse FE, Völcker HE: Static fundus perimetry using the scanning laser ophthalmoscope with an automated threshold strategy. Graefes Arch Clin Exp Ophthalmol 1995, 233: Rohrschneider K, Bethke-Jaenicke C, Becker M, Kruse FE, Blankenagel A, Völcker HE: Fundus-controlled examination of reading in eyes with macular pathology. Ger J Ophthalmol 1996, 5: Rohrschneider K, Becker M, Schumacher N, Fendrich T, Völcker HE: Normal values for fundus perimetry with the scanning laser ophthalmoscope. Am J Ophthalmol 1998, 126: Kruse FE, Joussen AM, Rohrschneider K, Becker MD, Völcker HE: Thalidomide inhibits corneal angiogenesis induced by vascular endothelial growth factor. Graefes Arch Clin Exp Ophthalmol 1998, 236: Rohrschneider K, Glück R, Becker M, Holz FG, Kruse FE, Fendrich T, Völcker HE: Scanning laser fundus perimetry before laser photocoagulation of well defined choroidal neovascularisation. Br J Ophthalmol 1997, 81: Rosenbaum JT, Becker MD, Schmith JR: Toward new therapies for ocular inflammation. Arch Soc Esp Oftalmol 2000, 75:

5 44. Rosenbaum JT, Becker MD: The tyranny of the anecdote: Waldenstroms s macroglobulinemia and scleritis. Ocul Immunol Inflamm 2000, 8: Smith J R, O'Rourke LM, Becker MD, Cao M, Williams K.A, Planck SR, Rosenbaum JT: Anti-rat ICAM-1 antibody does not influence the course of experimental melanin-induced uveitis. Curr Eye Res 2000, 5: Rosenbaum JT, Brischetto M, Crespo S, Bierwirth M, Oveson K, Planck SR, Becker MD: Simulateous in vivo imaging of leukocyte migration: heterogeneity among iris, limbus, and choroid vessels. Curr Eye Res 2002, 24: Fiehn C, Zierhut M, Becker M: Differenzialdiagnose der Uveitis. Dtsch Arztebl 2003, 100:A Lösch A, Scheuerle A, Rupp V, Auffarth G, Becker MD Transpalpebral measurement of intraocular pressure using the TGDc-01 tonometer versus standard Goldmann applanation tonometry. Graefe s Arch Clin Exp Ophthalmol 2005, 243: Martin T, Zhang G, Luo J, Jin L, Doyle T, Rajska1 B, Coffman J, Smith J, Becker M, Mackensen F, Khan M, Levinson R, Schumacher R, Wade K, Rosenbaum J, Reveille J: A Locus on Chromosome 9p Predisposes to a Specific Disease Manifestation, Acute Anterior Uveitis, in Ankylosing Spondylitis, a Genetically Complex, Multisystem, Inflammatory Disease. Arthritis Rheumatism 2005, 52: Bauer A, Fiehn C, Becker MD: Celecoxib, a selective inhibitor of cyclooxygenase 2 for therapy of diffuse anterior scleritis. Am J Ophthalmol 2005, 6: Wiehler U, Schmidt R, Skonetzki S, Becker MD: Computer gestütztes System zur Optimierung der differentialdiagnostischen Strategie bei Patienten mit sekundären Uveitisformen. Ophthalmologe 2006, 103: Lösch A, Flessa S, Fiehn C, Max R, Becker MD: Abklärung bei Uveitis: Kostenreduktion durch Befund-orientiertes diagnostisches Vorgehen. Ophthalmologe 2006, 103: Bauer A, Plaza D, Wetter T, Becker MD: Computergestütztes System zur Verlaufskontrolle intraokularer Entzündungen. Ophthalmologe 2005, 102: The Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 2005,

6 3: Mackensen F, Max R, Becker MD: Ocular manifestation of systemic disease: interferon therapy for ocular disease. Curr Opin Ophthalmol 2006, 17: Garweg JG, Becker M, Lommatzsch A, Bartz-Schmidt KU. Vitrektomie bei Uveitis im Kindes- und Jugendalter. Klin Monatsbl Augenheilkd 2007, 224: Niehues T, Winterhalter S, Zierhut M, Michels H, Becker MD, Heiligenhaus A. EBM-Analyse: klassische DMARDS (Disease- Modifying Antirheumatic Drugs) und Immunsuppressiva in Arthritis und Uveitis. Klin Monatsbl Augenheilkd 2007, 224: Mackensen F, Heinz C, Becker MD, Heiligenhaus A. Intravitreal Bevacizumab (Avastin TM ) as a treatment for refractory macular edema in patients with uveitis - a pilot study. Retina 2008, 28: Mackensen F, Becker MD, Wiehler U, Max R, Dalpke A, Zimmermann S. QuantiFERON TB-Gold-A New Test Strengthening Long-Suspected Tuberculous Involvement in Serpiginous-like Choroiditis. Am J Ophthalmol 2008, 146: Planck SR, Becker MD, Crespo S, Choi D, Galster K, Garman KL, Nobiling R, Rosenbaum JT. Characterizing extravascular neutrophil migration in vivo in the iris. Inflammation 2008, 31: Mansour AM, Mackensen F, Arevalo JF, Ziemssen F, Mahendradas P, Mehio-Sibai A, Hrisomalos N, Lai TY, Dodwell D, Chan WM, Ness T, Banker AS, Pai SA, Berrocal MH, Tohme R, Heiligenhaus A, Bashshur ZF, Khairallah M, Salem KM, Hrisomalos FN, Wood MH, Heriot W, Adan A, Kumar A, Lim L, Hall A, Becker M. Intravitreal bevacizumab in inflammatory ocular neovascularization. Am J Ophthalmol 2008, 146: Wrede J, Max R, Wiehler U, Becker M. Bilaterale Chorioretinitis mit Hiluslymphomen. Differenzialdiagnose und Therapie. Ophthalmologe 2008, 105: Jakob E, Reuland MS, Mackensen F, Harsch N, Fleckenstein M, Lorenz H, Max R, Becker MD. Uveitis Subtypes in a German Interdisciplinary Uveitis Center Analysis of 1916 Patients. Rheumatol 2009, 36: Mackensen F, Becker M, Zimmermann S. Tuberculous Uveitis. Ophthalmology 2010, 117:

7 65. Mackensen F, Max R, Becker MD: Interferons and their potential in the treatment of ocular inflammation. Clinical Ophthalmology : Neumann E, Frei E, Funk D, Becker MD, Schrenk HH, Müller-Ladner U, Fiehn C: Native albumin for targeted drug delivery. Expert Opin Drug Deliv 2010, 7: Heinz C, Heiligenhaus A, Becker MD: Therapiestrategien bei nichtinfektiösen entzündlichen Augenerkrankungen - Wann sollte welche systemische Therapie begonnen werden? Klin Monatsbl Augenheilkd. 2010, 227:R Mackensen F, Zimmermann S, Alle W, Max R, Jakob E, Becker MD, Thiemeyer D: Difficulties of interpreting Borrelia serology in patients with uveitis. Ocul Immunol Inflamm : Zweifel SA, Maygar I, Berger W, Tschuor P, Becker M, Michels S: Multimodal imaging of autosomal dominant drusen. Klin Monbl Augenheilkd : Heiligenhaus A, Michels H, Schumacher C, Kopp I, Neudorf U, Niehues T, Baus H, Becker M, Bertram B, Dannecker G, Deuter C, Foeldvari I, Frosch M, Ganser G, Gaubitz M, Gerdes G, Horneff G, Illhardt A, Mackensen F, Minden K, Pleyer U, Schneider M, Wagner N, Zierhut M: Evidence-based, interdisciplinary guidelines for antiinflammatory treatment of uveitis associated with juvenile idiopathic arthritis. Rheumatol Int : Michels S, Becker M, Wachtlin J, Binder S: The intravitreal injection: Variations in regulations, cost and reimbursement in Europe. Spektrum Augenheilkd : Geux-Crosier-Y, Becker M, Becht C, Sauvain MJ, Saurenmann R: Die nicht-infektiöse Uveitis im Kindesalter. Schweiz Med Forum : Thomas BC, Jacobi C, Korporal M, Becker MD, Wildemann B, Mackensen F. Ocular outcome and frequency of neurological manifestations in patients with acute posterior multifocal placoid pigment epitheliopathy (APMPPE). J Ophthalmic Inflamm Infect 2012, 2: Dobner BC, Max R, Becker MD, Heinz C, Veltrup I, Heiligenhaus A, Barisani-Asenbauer T, Mackensen F: A three-centre experience with adalimumab for the treatment of non-infectious uveitis. Br J Ophthalmol. 2013, 97:

8 75. Akduman L, Cetin EN, Levy J, Becker MD, Mackensen F, Lim LL. Spontaneous dissociation and dislocation of Retisert pellet. Ocul Immunol Inflamm 2013, 21: Mackensen F, Jakob E, Springer C, Dobner BC, Wiehler U, Weimer P, Rohrschneider K, Fiehn C, Max R, Storch-Hagenlocher B, Becker MD: Interferon versus Methotrexate in Intermediate Uveitis With Macular Edema: Results of a Randomized Controlled Clinical Trial. Am J Ophthalmol Jun Zweifel SA, Tönz MS, Pfenninger L, Becker M, Michels S: Intravitreal anti-vegf therapy for retinal macroaneurysm. Klin Monbl Augenheilkd 2013, 230: Buchprojekte 78. Becker MD, Davies J ed. Surgical management of inflammatory eye disease, Heidelberg: Springer, 2008 Buchbeiträge 79. Rosenbaum JT, Becker MD, Smith JR. Immunologic Ocular Disease. In: Rich RR, ed. Clinical Immunology Principles and Practice. Vol. 2. London: Mosby, 2001: Heiligenhaus A, Heinz C, Becker MD. Treatment of uveitis cataract. In: Krieglstein GK, Weinreb RN, ed. Cataract and Refractive Surgery - Essentials in Ophthalmology. Heidelberg: Springer, Becker MD, Heiligenhaus A, de Smet M, Davies JL. Vitrectomy in uveitis. In: Pleyer U, Mondino B ed. Uveitis and Immunological Disorders - Essentials in Ophthalmology. Heidelberg: Springer, Becker MD, Wiehler U, Holz FG. Acute zonal occult outer retinopathy (AZOOR). In: Holz FG, Spaide RF ed. Essentials in Ophthalmology. Heidelberg: Springer, Becker MD: Human T-Lymphotropic Virus Typ-1 (HTLV-1) assoziierte Augenerkrankungen. In: Zierhut, Jahn und Hansen ed. Viruserkrankungen des Auges, Heidelberg, Kaden Verlag, Becker MD: Uveitis Parasiten. In: Kampik, Grehn, Messmer ed. Facharztprüfung Augenheilkunde, Stuttgart: Thieme, Becker MD: Mykotische Uveitis. In: Kampik, Grehn, Messmer ed. Facharztprüfung Augenheilkunde, Stuttgart: Thieme, 2006

9 86. Becker MD, Wiehler U, Miller DW: Vasculitis in Multiple Sclerosis. In: Joussen AM, Gardner TW, Kirchhof B, Ryan SJ ed. Retinal Vascular Disease, Heidelberg: Springer, Becker MD, Jakob E, Mackensen F: Fuchs Uveitis Syndrome. In: Zierhut M ed. Uveitis, Heidelberg: Springer, 2013 in Vorbereitung 88. Mackensen F, Becker MD: Multiple Sklerosis. In: Zierhut M ed. Uveitis, Heidelberg: Springer, 2013 in Vorbereitung 89. Becker MD, Michels-S: Vitrektomie bei intraokularen Entzündungen In: Pleyer U ed, Intraokulare Entzündungen: Therapie Grundkonzepte: Springer 2013, in Vorbereitung